BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9444937)

  • 1. Heterogeneity of the inhibitory effects of IL-4 in two novel B lineage acute lymphoblastic leukemia cell lines.
    Renard N; Harada N; Callet-Bauchu E; Miyajima A; Duvert V; Banchereau J; Saeland S
    Leuk Res; 1997; 21(11-12):1037-46. PubMed ID: 9444937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferation of MIELIKI a novel t(7;9) early pre-B acute lymphoblastic leukemia cell line is inhibited concomitantly by IL-4 and IL-7.
    Renard N; Duvert V; Matthews DJ; Pagés MP; Magaud JP; Manel AM; Pandrau-Garcia D; Philippe N; Banchereau J; Saeland S
    Leukemia; 1995 Jul; 9(7):1219-26. PubMed ID: 7630198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Flt3 ligand and interleukin-7 on in vitro growth of acute lymphoblastic leukemia cells.
    Eder M; Hemmati P; Kalina U; Ottman OG; Hoelzer D; Lyman SD; Ganser A
    Exp Hematol; 1996 Feb; 24(2):371-7. PubMed ID: 8641368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of interleukin-7 and interleukin-3 with the CXCL12-induced proliferation of B-cell progenitor acute lymphoblastic leukemia.
    Juarez J; Baraz R; Gaundar S; Bradstock K; Bendall L
    Haematologica; 2007 Apr; 92(4):450-9. PubMed ID: 17488655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
    Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
    Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 4 inhibits in vitro proliferation of leukemic and normal human B cell precursors.
    Pandrau D; Saeland S; Duvert V; Durand I; Manel AM; Zabot MT; Philippe N; Banchereau J
    J Clin Invest; 1992 Nov; 90(5):1697-706. PubMed ID: 1385474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells: implication for targeted therapy.
    Sengupta TK; Leclerc GM; Hsieh-Kinser TT; Leclerc GJ; Singh I; Barredo JC
    Mol Cancer; 2007 Jul; 6():46. PubMed ID: 17623090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-lineage lymphoid blast crisis in juvenile chronic myelogenous leukemia: II. Interleukin-1-mediated autocrine growth regulation of the lymphoblasts.
    Attias D; Grunberger T; Vanek W; Estrov Z; Cohen A; Lau R; Freedman MH
    Leukemia; 1995 May; 9(5):884-8. PubMed ID: 7769852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-13 inhibits the proliferation of normal and leukemic human B-cell precursors.
    Renard N; Duvert V; Banchereau J; Saeland S
    Blood; 1994 Oct; 84(7):2253-60. PubMed ID: 7919343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG
    Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal variation in the B-lineage acute lymphoblastic leukemia response to multiple cytokines and bone marrow stromal cells.
    Shah N; Oseth L; Tran H; Hirsch B; LeBien TW
    Cancer Res; 2001 Jul; 61(13):5268-74. PubMed ID: 11431369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
    van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
    Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children.
    McKenna HJ; Smith FO; Brasel K; Hirschstein D; Bernstein ID; Williams DE; Lyman SD
    Exp Hematol; 1996 Feb; 24(2):378-85. PubMed ID: 8641369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers.
    Sasson SC; Smith S; Seddiki N; Zaunders JJ; Bryant A; Koelsch KK; Weatherall C; Munier ML; McGinley C; Yeung J; Mulligan SP; Moore J; Cooper DA; Milliken S; Kelleher AD
    Cytokine; 2010 Apr; 50(1):58-68. PubMed ID: 20060740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel B-cell precursor leukemia sister cell lines, NALM-33 and NALM-34, established from a patient with acute lymphoblastic leukemia.
    Matsuo Y; Drexler HG; Takeuchi M; Orita K
    Leuk Lymphoma; 1999 Nov; 35(5-6):513-26. PubMed ID: 10609789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of B lineage acute lymphoblastic leukemias (B-ALL) with regard to their in vitro spontaneous proliferation, growth factor response and BCL-2 expression.
    Pontvert-Delucq S; Hibner U; Vilmer E; Baillou C; Rohrlich P; Heymann D; Najman A; Guigon M; Lemoine FM
    Leuk Lymphoma; 1996 Apr; 21(3-4):267-80. PubMed ID: 8726408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High levels of p26BCL-2 oncoprotein retard taxol-induced apoptosis in human pre-B leukemia cells.
    Tang C; Willingham MC; Reed JC; Miyashita T; Ray S; Ponnathpur V; Huang Y; Mahoney ME; Bullock G; Bhalla K
    Leukemia; 1994 Nov; 8(11):1960-9. PubMed ID: 7526093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of breast cancer resistance protein in acute lymphoblastic leukemia.
    Plasschaert SL; van der Kolk DM; de Bont ES; Kamps WA; Morisaki K; Bates SE; Scheffer GL; Scheper RJ; Vellenga E; de Vries EG
    Clin Cancer Res; 2003 Nov; 9(14):5171-7. PubMed ID: 14613996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiling of transcription factors in B- or T-acute lymphoblastic leukemia/lymphoma and burkitt lymphoma: usefulness of PAX5 immunostaining as pan-Pre-B-cell marker.
    Nasr MR; Rosenthal N; Syrbu S
    Am J Clin Pathol; 2010 Jan; 133(1):41-8. PubMed ID: 20023257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of interleukin 10 in B lymphocytes of different origin.
    Finke J; Ternes P; Lange W; Mertelsmann R; Dölken G
    Leukemia; 1993 Nov; 7(11):1852-7. PubMed ID: 7694007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.